Abstract
Background: Chronic Pseudomonas aeruginosa infection is one of the major chal-lenges in the management of cystic fibrosis (CF) and is often associated with reduced lung function and increased complications. With the rising trend of antibiotic resistance, research-ers' attention has increasingly shifted toward complementary therapies. In this case report, the use of honey–thyme oxymel, a traditional Persian medicine preparation, was evaluated as an adjunctive treatment in a pediatric patient with CF. Case Presentation: The patient was an 11-year-old girl diagnosed with CF in infancy who had been affected by chronic P. aeruginosa infection for the past eight years. Despite strict adher-ence to standard antibiotic regimens, her throat cultures consistently remained positive. Anti-microbial susceptibility testing demonstrated resistance to multiple antibiotics. In addition to standard CF treatment, including inhaled and oral medications, vitamins, and chest physio-therapy, oral honey–thyme oxymel was added to her regimen at a dose of 5 mL twice daily for two months. Throat cultures obtained in the second, fourth, and sixth months were all negative for P. aeruginosa, representing the first microbiological eradication in the past eight years. Clinically, during six months of follow-up, the patient experienced easier sputum expectora-tion, fewer episodes of dyspnea, and no need for hospitalization. Her pulmonary function also showed significant improvement, with FEV₁ increasing from 73.3% to 83.2% in the second month. The treatment was generally well tolerated, with only a mild, transient cough reported as an adverse effect. Conclusion: This case suggests that adjunctive use of honey–thyme oxymel may be effective in achieving microbiological eradication and improving symptoms in patients with CF. How-ever, given the nature of a case report and the concurrent continuation of standard therapy, these improvements cannot be definitively attributed solely to oxymel consumption. There-fore, further studies, particularly controlled clinical trials, are warranted to accurately evaluate the safety and efficacy of this intervention.